Jefferies Group reissues "buy" rating for AmSurg stock: 5 points

Jefferies Group reiterated AmSurg stock's "buy" rating, according to a Newsway 21 report.

Here are five points:

1. Jefferies Group currently has a $96 target price on the stock.

2. AmSurg has a consensus rating of "buy" and an average target price of $93.20 from all the brokerages covering the stock.

3. The firm's 50-day moving average is $76.73 and its 200-day moving average is $75.07.

4. AmSurg has a one-year low of $54.11 and a one-year high of $87.42.

5. The company has a market capitalization of $4.12 billion.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast